Patents Assigned to Jouveinal, S.A.
  • Patent number: 4933331
    Abstract: 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thioacetate-17-butyrate and 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thiopropionate-17-butyrate, are anti-inflammatory agents.
    Type: Grant
    Filed: November 4, 1985
    Date of Patent: June 12, 1990
    Assignee: Jouveinal, S.A.
    Inventors: Gilbert G. Aubard, Agnes G. Grouhel, Jean-Louis Junien, Claude P. Roux, Dieran R. Torossian
  • Patent number: 3934016
    Abstract: Pharmaceutical preparation and method for percutaneous treatment of edemas, with the pharmaceutical preparation comprising an active element consisting of acetazolamide in a concentration of between 1 to 50% incorporated in a vehicle which is compatible with percutaneous administration.
    Type: Grant
    Filed: May 24, 1971
    Date of Patent: January 20, 1976
    Assignee: Jouveinal, S.A.
    Inventors: Claude Paul Roux, Dieran Robert Torossian